Почетна › Срцева слабост › Колорадо
Клинички испитувања за Срцева слабост во Колорадо
23 студии за Срцева слабост бараат учесници на локации во Колорадо.
Градови во Колорадо
Официјален текст на студијата (англиски)
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Univ of Colorado at Denver, Aurora
Се регрутираФаза 2
Возраст од 40 до 84 · Сите полови · Ажурирано 5.10.2026 · NCT06979362Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Aurora
Се регрутираФаза 3
Возраст од 18 до 130 · Сите полови · Ажурирано 2.10.2026 · NCT06307652A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Colorado Springs
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Rocky Mountain Regional VA Medical Center, Aurora
Се регрутираФаза 3
Возраст од 18 до 85 · Сите полови · Ажурирано 24.9.2026 · NCT06736574Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Aurora
- Research Site, Englewood
Се регрутираФаза 3
Возраст 40 и постари · Сите полови · Ажурирано 15.9.2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Aurora, CO Investigative Site 10001, Aurora
- Denver, CO Investigative Site 10005, Denver
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06008197A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10001, Aurora, CO, Aurora
- CON-10005, Denver, CO, Denver
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06024746Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Hospital Colorado ( Site 0012), Aurora
Се регрутираФаза 2/3
29 Days – 17 Years · Сите полови · Ажурирано 28.8.2026 · NCT05714085Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
- Denver Health and Hospital Authority, Denver
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT07435662Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Children's Hospital Colorado, Aurora
Се регрутираНабљудувачка студија
До возраст 18 · Сите полови · Ажурирано 25.8.2026 · NCT06532890Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Aurora
- Centennial
- Colorado Springs
- и уште 1
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 20.8.2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- UC Denver, AMC, Aurora
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Univ of Colorado at Denver, Aurora
- VA Eastern Colorado Health Care System, Aurora
- Intermountain Heart & Vascular, Denver
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07567001Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- University of Colorado, Aurora
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 13.7.2026 · NCT06526988A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10110, Aurora, CO, Aurora
- FIN-10001, Aurora, CO, Aurora
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT06033950A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
Се регрутираФаза 3
До возраст 18 · Сите полови · Ажурирано 29.6.2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
Се регрутираФаза 3
6 Months – 17 Years · Сите полови · Ажурирано 15.6.2026 · NCT07188805The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- South Denver Cardiology, Littleton
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 13.4.2026 · NCT03142152Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
- Boulder Heart, Boulder
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 13.4.2026 · NCT07224906Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Barbara Davis Center / University of Colorado Denver, Aurora
Се регрутираФаза 3
Возраст од 18 до 75 · Сите полови · Ажурирано 24.3.2026 · NCT06217302Left vs Left Randomized Clinical Trial
- University of Colorado (Anschutz Medical Campus), Denver
- South Denver Cardiology Associates, Littleton
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2025 · NCT05650658Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- University of Colorado - Anschutz Medical Campus, Aurora
Се регрутираФаза 1
Возраст од 18 до 65 · Сите полови · Ажурирано 6.2.2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- University of Colorado, Denver, Aurora
Се регрутираНабљудувачка студија
Возраст од 14 до 65 · Сите полови · Ажурирано 1.11.2024 · NCT06311708Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.